2023
Entrant
Category
Client's Name
Country / Region
About The Entry
Unlocking the Proteome -The NULISA™ Platform sets a new standard in proteomic analysis with attomolar sensitivity, allowing for unprecedented biomarker detection and quantitation.
By leveraging a proprietary sequential immunocomplex capture and release mechanism and the latest advances in Next Generation Sequencing (NGS), the NULISA technology provides both ultra-high sensitivity and scalable multiplexing.
Entrant
DataPath, Inc.
Category
Marketing & Promotional - Promotional
Country / Region
United States
Entrant
Tailfeather
Category
Corporate Identity - Logos
Country / Region
United States
Entrant
Freelance
Category
App - Mobile App / Other___
Country / Region
Latvia
Entrant
Mindsailing
Category
Branded Content - E-Book
Country / Region
United States